Clinical trial
Research on the Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via Digital Droplet PCR (ddPCR) From Peripheral Blood in NSCLC Patients
NCT05458726 is registered in ClinicalTrials.gov with Peking Union Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Research on the Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via Digital Droplet PCR (ddPCR) From Peripheral Blood in NSCLC Patients
- Lead sponsor
- Peking Union Medical College
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 15, 2020
- Completion date
- October 31, 2022
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ddpcr, egfr t790m, non-small cell lung cancer, osimertinib